Methods to improve the efficacy of treatment of inflammatory diseases of small pelvic organsassociated with a mycoplasma infection

Abstract

The authors present the results of examination and treatment of 40 female patients with recurrent urogenital infections,
who had optional and/or obligate anaerobes revealed by bacteriological tests (patients were withdrawn from the study
if Neisseria gonorrhoeae, C. trachomatis, Treponema pallidum or Trichomonas vaginalis were revealed). The patients
received treatment with doxycycline or josamycin depending on the results of determination of sensitivity of cultivated
microorganisms. Evident positive dynamics of clinical manifestations was recorded as a result of use of these drugs.
Normalization of biocenosis and absence of opportunistic flora were recorded for 38 patients.

References

  1. Кира Е.Ф. Инфекции и репродуктивное здоровье беременных. Современные методы диагностики, терапии и профилактики ИППП и других урогенитальных инфекций. Рабочее совещание дерматовенерологов и акушеров-гинекологов. М.: 1999; 22-25.
  2. Байрамова Г.Р. Бактериальный вагиноз. В кн. Поликлиническая гинекология. М.: МЕДпресс-информ 2004; 126-35.
  3. Воропаева С.Д. Микрофлора женских половых путей и ее чувствительность к антибактериальным препаратам. Антибиотики и химиотер. 1999; 44 (3): 42-5.
  4. Цвелев Ю.В., Кочеровец В.И., Кира Е.Ф. Анаэробная инфекция в акушерстве и гинекологической практике. СПб., 1995.
  5. Haggerty C.L., Shultz R., Ness R.B. Lower quality of life among women with chronic pelvic pain after inflammatory disease. Obstetr Gynecol 2003; 102 (5): 934-9.
  6. Шатунова Е.П. Применение вильпрофена у больных с сальпингоофоритом. Акуш. и гин. 2002; 5: 49-50.
  7. Bahar H., Torun M.M., Ocer F. et al. Mobiluncus species in gynecological and obstetric infections: antimicrobial resistance and prevalence in a Turkish population. Int J Antimicrob Agents 2005; 25 (3): 268-71.
  8. Gil M.C., Pena F.G., Hermos O. at al. Mycoplasma agalactiae putrefa ciens. J Vet Med Infet Dis Vet Public Health 2003; 10: 484-7.
  9. Ross J.D. Is Mycoplasma genitalium a cause of pelvic inflammatory disease? Infect Dis Clin North Am 2005; 2: 407-13.
  10. Moller B.R., Obel N., Moller T.R. Mycoplasma genitalium a new chal lenge in sexually transmitted diseases. Ugeskr. Laeger 2005; 35: 3291-4.
  11. Никонов А.П. Диагностика и антимикробная химиотерапия инфекций верхнего отдела генитального тракта. Гинекология (спецвы- пуск) 2004.
  12. Кисина В.И., Забиров К.И. Урогенитальные инфекции у женщин. Клиника, диагностика и лечение. М: МИА 2005.
  13. WHO 2006. Global strategy for the prevention and control of sexually transmitted infections: 2006-2015: breaking the chain of transmission. Available at: http://whqlibdoc.who.int/publications/ 2007/9789244563472_rus.pdf. Last accessed 29, May 2011.
  14. Togni G., Battini V., Bulgheroni A. et al. In vitro activity of nifuratel on vaginal bacteria: could it be a good candidate for the treatment of bacterial vaginosis? Antimicrobial agents and chemotherapy 2011; 55 (5): 2490-2.
  15. Гущин А.Е., Бурцев О.А., Рыжих П.Г. и др. Мониторинг лечения пациентов с инфекцией, вызванной Mycoplasma genitalium с помощью методов ПЦР и НАСБА в реальном времени. Клин. дерматол. и венерол. 2009; 4: 58-63.
  16. Юрьев С.Ю., Аббасов В.И., Девятьяров Л.Л. и др. К вопросу о специфичности влияния Mycoplasma genitalium на течение беременности. Гинекология 2009; 11 (4): 20-3.
  17. th WHO Model List of Essential Medicines. Unedited report of the 18th Expert Committee on the Selection and Use of Essential Medicines. 21-25 March 2011, Accra, Ghana. Available at: http://www.who.int/selection_ medicines/Complete_UNEDITED_TRS_18th. pdf. Last access 25, May 2011.

Statistics

Views

Abstract: 777

PDF (Russian): 460

Article Metrics

Metrics Loading ...

Dimensions

PlumX

Refbacks

  • There are currently no refbacks.

Copyright (c) 2011 Perlamutrov Y.N., Chernova N.I., Perlamutrov Y.N., Chernova N.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies